Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Statistical and health economic analysis plan for the 65 trial in article*

Схожие документы

• Evaluating the clinical and cost-effectiveness of permissive hypotension in critically ill patients aged 65 years or over with vasodilatory hypotension: Protocol for the 65 randomised clinical trial
  по: Richards-Belle, Alvin, et al.
  Опубликовано: (2020)
• Reduced exposure to vasopressors through permissive hypotension to reduce mortality in critically ill people aged 65 and over: the 65 RCT.
  по: Mouncey, Paul R, et al.
  Опубликовано: (2021)
• Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical Trial
  по: Lamontagne, François, et al.
  Опубликовано: (2020)
• Psychological outcomes following a nurse-led preventative psychological intervention for critically ill patients trial: Statistical and health economic analysis plan
  по: Wulff, Jerome, et al.
  Опубликовано: (2018)
• Orthostatic hypotension and vasodilatory peptides in bronchial carcinoma.
  по: Gosney, M A, et al.
  Опубликовано: (1995)